XC~WMAV){Q'@2HH$4SL0*F3S%)
SYSTEM PROCESSING...
XC~WMAV){Q'@2HH$4SL0*F3S%)
SYSTEM PROCESSING...
Posted: 2025-04-09 15:35:18 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-09 15:35:39 UTC
Verified By
Rollup News
The Phase 3 clinical trial of the M72/AS01E tuberculosis (TB) vaccine candidate has reached its one-year anniversary since launch. The trial is being conducted across 54 sites in five countries.
M72/AS01E tuberculosis vaccine candidate
Phase 3 clinical trial
One-year anniversary
54 sites in five countries